CARDIOVASCULAR RISK PROFILES OF MONOTHERAPY VS. COMBINATION THERAPY IN TYPE 2 DIABETES. rjnmsr 2025, 3 (7), 140-147. https://doi.org/10.63075/7swvcz45.